The prolactin response to buspirone in poststroke depression: A preliminary report

Journal of Affective Disorders

Volumn 59, Issue 2, 2000, Pages 169-173

  Sevinçok, Levent ^a   Erol, Atila ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Buspirone; Depression; Poststroke

Indexed keywords

BUSPIRONE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; FEMALE; HEMISPHERIC DOMINANCE; HORMONE RESPONSE; HUMAN; MALE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROLACTIN RELEASE; RATING SCALE; SEROTONINERGIC TRANSMISSION; STROKE;

ADULT; AGED; BUSPIRONE; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; DEPRESSION; DOMINANCE, CEREBRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX;

EID: 0034257068     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00143-3     Document Type: Article

References (20)

1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., rev. 1987;American Psychiatric Press, Washington, DC.
2. Barry S., Dinan T.C. Alpha-2 adrenergic receptor function in post-stroke depression. Psychol. Med. 20:1990;305-309.
3. Bryer J.B., Starkstein S.E., Votypka V., Parikh R.M., Price T.R., Robinson R.G. Reduction of CFS monoamine metabolites in poststroke depression: a preliminary report. Neuropsychiatry Clin. Neurosci. 4:1992;440-442.
4. Coccaro E.F., Gabriel S., Siever L.J. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacol. Bull. 26:1990;393-405.
5. Cowen P.J., Anderson I.M., Grahame-Smith D.G. Neuroendocrine effects of azapirones. J. Clin. Psychopharmacol. 10:1990;21-25.
6. Dinan T.G., Barry S., Yatham L.N., Mobayed M., O'Hanlon M. The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle. Int. Clin. Psychopharmacol. 5:1990;119-123.
7. Hamilton M.A. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
8. Lipsey J.R., Robinson R.G., Pearlson G.D. Dexamethasone suppression test and mood following strokes. Am. J. Psychiatry. 142:1985;318-323.
9. Maes M., Jacops M.-P., Suy E., Minner B., Raus J. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major depressed patients. Neuropsychobiology. 21:1989;192-196.
10. Maes M., D'Hondt P., Suy E., Minner B., Vandervorst C., Raus J. HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 15:1991;781-790.
11. Mayberg H.S., Robinson R.G., Wong D.F., Parikh R., Bolduc P., Starkstein S.E., Price T., Dannals R.F., Links J.M., Wilson A.A., Ravert H.T., Wagner H.N. PET imaging of cortical S2 serotonin receptors after stroke: lateralised changes and relationship to depression. Am. J. Psychiatry. 145:1988;937-943.
12. Meltzer H.Y., Flemming R., Robertson A. The effect of buspirone on prolactin and growth hormone secretion in man. Arch. Gen. Psychiatry. 40:1983;1009-1102.
13. Meltzer H.Y., Wiita B., Robertson A., Tricou B.J., Lowy M., Perline R. Effect of 5-hydroxytriptophan on serum cortisol levels in major affective disorders: enhanced response in depression and mania. Arch. Gen. Psychiatry. 41:1984;366-374.
14. Meltzer H.Y., Maes M. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Biol. Psychiatry. 35:1994;316-323.
15. Mobayed M., Dinan T.G. Buspirone/prolactin response in post-head injury depression. J. Affect. Disord. 19:1990;237-241.
16. Morris P.L., Robinson R.G., Raphael B., Hopwood M.J. Lesion location and post-stroke depression. J. Neuropsychiatry Clin. Neurosci. 8:1996;399-403.
17. Olsson T., Astrom M., Eriksson S. Hypercotisolism revealed by the dexamethasone suppression test with acute ischemic stroke. Stroke. 20:1989;1685-1690.
18. Peroutka S.J. Selective interactions of novel anxiolytics with 5-hydroxytryptamine receptors. Biol. Psychiatry. 20:1985;971-979.
19. Robinson R.G., Kubos K.L., Starr L.B. Mood disorders in stroke patients: importance of lesion location. Brain. 107:1984;81-93.
20. Schwartz J.A., Speed N.M., Brunberg J.A., Brewer T.L., Brown M., Greden J.F. Depression in stroke rehabilitation. Biol. Psychiatry. 33:1993;694-699.